Navigation Links
XLHealth Statement on Senate Finance Committee Roundtable on Healthcare Reform
Date:4/22/2009

BALTIMORE, April 22 /PRNewswire/ -- XLHealth, owner and operator of Care Improvement Plus, one of the nation's largest Medicare Advantage chronic condition Special Needs Plans, supports the proposed areas of reform that the Senate Finance Committee discussed in the first of a series of round-table discussions on potential methods for overhauling the current healthcare system. The hearing's focus on using the Medicare system as a model for incorporating improved care coordination and chronic care management is well aligned with XLHealth's core mission and focus to improve quality and reduce healthcare costs for the nation's underserved and chronically ill Medicare beneficiaries.

"This meeting sent a clear message that it is time to move forward on developing a healthcare reform plan that will break the cycle of 'sick care' and focus on creating a system where preventive care, disease management, and improved care coordination are more encouraged," says Robb Cohen, XLHealth's chief government affairs officer. "As a comprehensive reform plan evolves, we will continue to work with congressional leaders, CMS, and others to develop innovative Medicare-based solutions that will best serve the nation's chronically ill beneficiaries, since they largely make up the approximately 20 percent of beneficiaries that account for nearly 80 percent of current Medicare spending."

About XLHealth

XLHealth (http://www.xlhealth.com), a Baltimore-based organization focused on improving the healthcare of chronically ill seniors, is the owner and operator of Care Improvement Plus, one of the nation's largest chronic condition special needs plans. Care Improvement Plus provides a complete Medicare Advantage Part D health plan and disease management services to Medicare beneficiaries living with heart failure, diabetes, chronic obstructive pulmonary disease and/or end-stage renal disease. XLHealth has earned Full Accreditation from the National Committee for Quality Assurance (NCQA) under its standards for patient and practitioner-oriented accreditation of disease management programs.


'/>"/>
SOURCE XLHealth
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. XLHealth Corporation Announces Executive Changes
2. XLHealth Appoints New CFO, Adds Two Additional Executives
3. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
4. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
5. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
6. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
7. Statement by Oscar S. Wyatt, Jr.
8. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
9. Pelosi Statement on Proposed Entitlement Task Force
10. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
11. Statement on House/Senate Agreement on SCHIP Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Are you investing in the safety of your ... drownings during the summer. While most of us assume this type of accident will ... Very few people are taking the time to learn how to respond effectively or ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... announce the ATA 2017 President’s Awards recipients, comprised of organizations and individuals ... delivery. , The ATA 2017 President’s Awards recognize individuals and organizations ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may ... pelvic conditions and has helped many women become pregnant upon treating their diagnosis. ... office-based and simple outpatient evaluations. We can provide the necessary information to ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... ecosystem and domain expertise for sponsors and CROs to speed clinical development, ... management (RTSM) software platform. Bioclinica AGILE RTSM provides seamless clinical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor ... I/II HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
Breaking Medicine Technology: